Table 1.
Selected characteristics of Adherent and Non-adherent HAART users at the visit just prior to HAART initiation.
| HAART Adherence |
|||
|---|---|---|---|
| Characteristic | No | Yes | P |
| N=142 | N=144 | ||
| Age group | 0.45** | ||
| <35 y | 43 (30%)* | 35 (24%) | |
| 35–39 y | 33 (23%) | 43 (30%) | |
| 40–44 y | 37 (26%) | 30 (21%) | |
| >=45 y | 29 (20%) | 36 (25%) | |
| Race | 0.21 | ||
| White | 17 (12%) | 28 (19%) | |
| Black | 91 (64%) | 82 (57%) | |
| Hispanic and Others | 34 (24%) | 34 (24%) | |
| CD4+ T-cell count (cells/mm3) | 0.24** | ||
| CD4>500 | 33 (23%) | 32 (22%) | |
| 200≤CD4≤500 | 77 (54%) | 67 (47%) | |
| CD4<200 | 32 (23%) | 45 (31%) | |
| Number of Male sex partners in the past 6 months | 0.34** | ||
| 0 | 37 (27%) | 47 (33%) | |
| 1 (married) | 23 (17%) | 19 (14%) | |
| 1 (single) | 55 (40%) | 58 (41%) | |
| >=2 | 21 (15%) | 17 (12%) | |
| Smoking status | 0.10** | ||
| None | 26 (19%) | 31 (25%) | |
| Former Smoker | 28 (21%) | 35 (28%) | |
| Current Smoker <10 pack years | 41 (31%) | 30 (24%) | |
| Current Smoker >=10 pack years | 39 (29%) | 30 (24%) | |
| Any HPV, number of individual HPV types | 0.21** | ||
| 0 | 49 (40%) | 57 (45%) | |
| 1 | 40 (33%) | 35 (29%) | |
| >1 | 34 (28%) | 27 (23%) | |
| Oncogenic HPV, number of individual HPV types | 0.61** | ||
| 0 | 88 (72%) | 90 (76%) | |
| 1 | 27 (22%) | 21 (18%) | |
| >1 | 8 (7%) | 8 (7%) | |
| Any SIL | 0.16** | ||
| No | 83 (76%) | 88 (83.81) | |
| Low Grade SIL | 24 (22%) | 16 (15.24) | |
| High Grade SIL | 2 (2%) | 1 (0.95) | |
| Oncogenic HPV-positive SIL | 0.98 | ||
| No | 83 (76%) | 88 (84%) | |
| Yes | 26 (24%) | 17 (16%) | |
*
Certain data were missing at baseline for selected patients, and percentages do not always add up to 100% due to rounding.
**
Two-sided Cochran-Mantel-Haenszel test. All other P values were determined with the two-sided Pearson’s chi-square test.